Lantheus Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Lantheus Holdings, Inc. details strategic acquisitions, pipeline advancements, and corporate governance updates in its 2026 Proxy Statement, emphasizing a focus on radiodiagnostics and long-term value creation.
NASDAQ
Lantheus Holdings will hold its annual stockholders meeting on May 1, 2025, to vote on director elections, executive compensation, auditor ratification, and a shareholder proposal regarding board declassification.
NASDAQ
Lantheus Holdings announces record revenue and strong free cash flow in 2024, driven by PYLARIFY and DEFINITY, and outlines strategic investments in neurology and oncology for future growth.
NASDAQ
Lantheus Holdings will hold its annual stockholders meeting on April 25, 2024, to vote on director elections, executive compensation, an equity incentive plan amendment, and auditor ratification.
NASDAQ
DEF 14A: Lantheus Holdings Aims to Boost Shareholder Value with Strategic Growth and Governance Enhancements
Lantheus Holdings' 2024 proxy statement highlights a year of robust financial performance, strategic portfolio expansion, and a commitment to sustainable shareholder value, alongside key governance proposals for the upcoming annual meeting.